Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Waters Corp
WAT
$40.5B
| $273M | 0.02% |
719,171
-18,081
| -2% | -$6.65M |
|
777
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.87B
| $273M | 0.02% |
4,460,387
-397,779
| -8% | -$24M |
|
778
British American Tobacco
BTI
$124B
| $272M | 0.02% |
4,812,348
-452,113
| -9% | -$24.7M |
|
779
Principal Financial Group
PFG
$24.4B
| $272M | 0.02% |
3,079,857
+55,669
| +2% | +$4.7M |
|
780
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
| $271M | 0.02% |
6,476,051
+488,701
| +8% | +$20.4M |
|
781
Capital Group Core Equity ETF
CGUS
$11.9B
| $270M | 0.02% |
6,715,499
+592,642
| +10% | +$23.7M |
|
782
Huntington Ingalls Industries
HII
$13.1B
| $269M | 0.02% |
792,241
-23,777
| -3% | -$7.38M |
|
783
AB InBev
BUD
$164B
| $269M | 0.02% |
4,205,767
+966,378
| +30% | +$60M |
|
784
Equity Residential
EQR
$24.7B
| $269M | 0.02% |
4,270,623
+561,032
| +15% | +$34.4M |
|
785
Flutter Entertainment
FLUT
$16.7B
| $268M | 0.02% |
1,247,956
-614,439
| -33% | -$138M |
|
786
Packaging Corp of America
PKG
$22.6B
| $267M | 0.02% |
1,293,360
-150,131
| -10% | -$30.5M |
|
787
SBA Communications
SBAC
$19.1B
| $267M | 0.02% |
1,377,798
+23,844
| +2% | +$4.61M |
|
788
Idacorp
IDA
$8.14B
| $266M | 0.02% |
2,103,940
+188,845
| +10% | +$24.6M |
|
789
Leidos
LDOS
$17.6B
| $266M | 0.02% |
1,474,369
-75,865
| -5% | -$14.4M |
|
790
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.99B
| $266M | 0.02% |
6,604,998
+913,028
| +16% | +$37M |
|
791
VICI Properties
VICI
$28.9B
| $266M | 0.02% |
9,451,047
+373,713
| +4% | +$11.1M |
|
792
First Citizens BancShares
FCNCA
$25.4B
| $264M | 0.02% |
123,048
+29,681
| +32% | +$55.9M |
|
793
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.47B
| $264M | 0.02% |
5,367,743
-468,393
| -8% | -$23M |
|
794
Conagra Brands
CAG
$7.12B
| $264M | 0.02% |
15,229,557
+2,376,823
| +18% | +$42.2M |
|
795
Teva Pharmaceuticals
TEVA
$41.3B
| $264M | 0.02% |
8,444,801
+1,969,783
| +30% | +$48.5M |
|
796
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
| $263M | 0.02% |
8,712,343
+1,017,975
| +13% | +$30.8M |
|
797
Incyte
INCY
$24.8B
| $263M | 0.02% |
2,663,823
+23,087
| +0.9% | +$2.23M |
|
798
Edison International
EIX
$26.1B
| $263M | 0.02% |
4,382,331
-341,214
| -7% | -$19.6M |
|
799
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
| $262M | 0.02% |
2,306,483
+145,362
| +7% | +$15M |
|
800
Praxis Precision Medicines
PRAX
$10B
| $262M | 0.02% |
889,889
+246,394
| +38% | +$45.9M |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.